Shaping Tomorrow's Lifespan

A global nexus of advanced aging research, breaking news, unified data, and breakthrough collaboration.

Project LongevityOne is dedicated to finding a foundational cure for human aging. We consolidate biology and technology insights, streamlining access for scientists, bio-hackers, and longevity advocates. As a central repository, we spark innovation, foster collaboration, and accelerate the global effort to understand, slow, and reverse aging. We believe this pivotal moment in human history can redefine what it means to grow older.

Longevity Leaders

Roots By Genetic Arts

DNA‑based custom hair‑growth solutions

The Latest News

Precision DNA Profiling for Next Generation Hair Loss Solutions

pexels-cdc-library-3992944

The DHT Story in Hair Loss-Still True, but PGD2 Writes a Missing Chapter

Biolinq lands 0m to bring wearable metabolic biosensor to market

Biolinq lands $100m to bring wearable metabolic biosensor to market

Trending Topics

Exosomes

Hydrocortisone

Vitamin E

Tretinoin

Caffeine (Hair Loss)

Cytokines

Vasodilators

Bimatoprost

Niacinamide

Niacinamide (nicotinamide) boosts intracellular NAD⁺, supports DNA repair, and exhibits anti‑inflammatory effects in keratinocytes. Topical 4 % solutions improve hair fullness and reduce scalp irritation.

Spironolactone

Spironolactone is a mineralocorticoid receptor antagonist with anti‑androgen properties. Oral doses 50–200 mg/day lower systemic and follicular DHT, making it a mainstay for female‑pattern hair loss.

Androgenetic alopecia

Androgenetic alopecia is a progressive, patterned miniaturisation of hair follicles driven by genetic susceptibility to dihydrotestosterone. It affects up to 80 % of men and 50 % of women over a lifetime.

Timapiprant

Timapiprant (OC000459) is another highly selective DP2 antagonist studied for allergic inflammation. By blocking PGD2 it is theorised to relieve the growth‑inhibiting milieu in AGA scalps.

Press Releases

New Wikis